Array comparative genomic hybridization identifies a heterozygous deletion of exon 3 of the RYR2 gene

References

• Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69–74.
   PubMed Web of Science ®Google Scholar
• Swan H, Piippo K, Viitasalo M, Heikkila P, Paavonen T, Kainulainen K, et al. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol. 1999;34:2035–42.
   PubMed Web of Science ®Google Scholar
• Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001;103:196–200.
   PubMed Web of Science ®Google Scholar
• Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation. 2001;103:485–90.
   PubMed Web of Science ®Google Scholar
• Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O, et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet. 2001;69:1378–84.
   PubMed Web of Science ®Google Scholar
• Postma AV, Denjoy I, Hoorntje TM, Lupoglazoff JM, Da Costa A, Sebillon P, et al. Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. Circ Res. 2002;91:e21–6.
   PubMed Web of Science ®Google Scholar
• Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8:1308–39.
   PubMed Web of Science ®Google Scholar
• Vega AL, Tester DJ, Ackerman MJ, Makielski JC. Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia. Circ Arrhythm Electrophysiol. 2009;2:540–7.
   PubMed Web of Science ®Google Scholar
• Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, van Tintelen JP, et al. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis. J Am Coll Cardiol. 2009;54:2065–74.
   PubMed Web of Science ®Google Scholar
• Bhuiyan ZA, van den Berg MP, van Tintelen JP, Bink-Boelkens MT, Wiesfeld AC, Alders M, et al. Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features. Circulation. 2007;116:1569–76.
   PubMed Web of Science ®Google Scholar
• Marjamaa A, Laitinen-Forsblom P, Lahtinen AM, Viitasalo M, Toivonen L, Kontula K, et al. Search for cardiac calcium cycling gene mutation in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia. BMC Med Genet. 2009;10:12.
   PubMedGoogle Scholar
• Ohno S, Omura M, Kawamura M, Kimura H, Itoh H, Makiyama T, et al. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction. Europace. 2014;16:1646–54.
   PubMed Web of Science ®Google Scholar
• Szentpali Z, Szili-Torok T, Caliskan K. Primary electrical disorder or primary cardiomyopathy? A case with a unique association of noncompaction cardiomyopathy and cathecolaminergic polymorphic ventricular tachycardia caused by ryanodine receptor mutation. Circulation. 2013;127:1165–6.
   PubMed Web of Science ®Google Scholar
• Tester D, Kopplin L, Will M, Ackerman M. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Heart Rhythm. 2005;2:1099–105.
   PubMed Web of Science ®Google Scholar
• Marquis-Nicholson R, Doherty E, Love J, Lan C, George A, Thrush A, et al. Array-based identification of copy number changes in a diagnostic setting: simultaneous gene-focused and low resolution whole human genome analysis. Sultan Qaboos Univ Med J. 2013;13:69–79.
   Google Scholar
• Marquis-Nicholson R, Lai D, Lan CC, Love JM, Love DR. A streamlined protocol for molecular testing of the DMD gene within a diagnostic laboratory: a combination of array comparative genomic hybridisation and bidirectional sequence analysis. ISRN Neurol. 2013;2013:908317.
   Google Scholar
• Marquis-Nicholson R, Prosser D, Love J, Love D. Gene dosage analysis in a clinical environment: gene-targeted microarrays as the platform-of-choice. Microarray. 2013;2:51–62.
   Google Scholar
• Marquis-Nicholson R, Prosser DO, Love JM, Zhang L, Hayes I, George AM, et al. Array comparative genomic hybridization identifies a heterozygous deletion of the entire KCNJ2 gene as a cause of sudden cardiac death. Circ Cardiovasc Genet. 2014;4:17–22.
   Google Scholar
• Roche. Roche NimbleGen Array User’s Guide: CGH and CGH/LOH Arrays v9.1. Available from http://www.nimblegen.com/downloads/support/05434483001_NG_CGHLOH_UGuide_v9p1.pdf. [Accessed in October 2013].
   Google Scholar
• UCSC Genome Browser. Available from http:/genome.ucsc.edu/. [Accessed in October 2013].
   Google Scholar
• Biomatters. GeneGene vR6.1.6. Available from http://www.geneious.com/. [Accessed in October 2013].
   Google Scholar
• Bers D. Cardiac excitation-contraction coupling. Nature. 2001;415:198–205.
   Web of Science ®Google Scholar
• Lobo P, Kimlicka L, Tung C, van Petegem F. The deletion of exon 3 in the cardiac ryanodine receptor is rescued by β strand switching. Structure. 2011;19:790–8.
   PubMed Web of Science ®Google Scholar
• Tang Y, Tian X, Wang R, Fill M, Chen SR. Abnormal termination of Ca2+ release is a common defect of RyR2 mutations associated with cardiomyopathies. Circ Res. 2012;110:968–77.
   PubMed Web of Science ®Google Scholar
• Beery TA, Shah MJ, Benson DW. Genetic characterization of familial CPVT after 30 years. Biol Res Nurs. 2009;11:66–72.
   PubMed Web of Science ®Google Scholar
• Creighton W, Virmani R, Kutys R, Burke A. Identification of novel missense mutations of cardiac ryanodine receptor gene in exercise-induced sudden death at autopsy. J Mol Diagn. 2006;8:62–7.
   PubMed Web of Science ®Google Scholar
• Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation. 1995;91:1512–19.
   PubMed Web of Science ®Google Scholar
• Postma AV, Denjoy I, Kamblock J, Alders M, Lupoglazoff JM, Vaksmann G, et al. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet. 2005;42:863–70.
   PubMed Web of Science ®Google Scholar
• Lehnart SE, Mongillo M, Bellinger A, Lindegger N, Chen BX, Hsueh W, et al. Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. J Clin Invest. 2008;118:2230–45.
   PubMed Web of Science ®Google Scholar